Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02669511
Title PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors PIQUR Therapeutics AG
Indications

central nervous system lymphoma

Therapies

PQR309

Age Groups: senior | adult
Covered Countries


No variant requirements are available.